This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Babylon Holdings Valuation

Is 7UK0 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 7UK0 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 7UK0's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 7UK0's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 7UK0?

Key metric: As 7UK0 is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for 7UK0. This is calculated by dividing 7UK0's market cap by their current revenue.
What is 7UK0's PS Ratio?
PS Ratio	0.0004x
Sales	US$1.15b
Market Cap	US$422.63k

7UK0 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	0.2x
Enterprise Value/EBITDA	-1.2x
PEG Ratio	n/a

Price to Sales Ratio vs Peers

How does 7UK0's PS Ratio compare to its peers?

The above table shows the PS ratio for 7UK0 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PS	Estimated Growth	Market Cap
Peer Average	1.1x
IS8 ifa systems	0.8x	n/a	€7.3m
MF6 MagForce	0.3x	n/a	€366.9k
AJ91 DocCheck	0.8x	n/a	€41.4m
M3V MeVis Medical Solutions	2.5x	n/a	€44.4m
7UK0 Babylon Holdings	0.0004x	n/a	€422.6k

Price-To-Sales vs Peers: 7UK0 is good value based on its Price-To-Sales Ratio (0x) compared to the peer average (1.3x).

Price to Sales Ratio vs Industry

How does 7UK0's PS Ratio compare vs other companies in the European Healthcare Services Industry?

6 Companies	Price / Sales	Estimated Growth	Market Cap
Industry Avg.	2.2x	8.5%
7UK0 Babylon Holdings	0.0004x	n/a	US$422.63k

6 Companies		Estimated Growth	Market Cap
Industry Avg.	2.2x	30.2%
7UK0 Babylon Holdings	0.0004x	n/a	US$422.63k

No more companies

Price-To-Sales vs Industry: 7UK0 is good value based on its Price-To-Sales Ratio (0x) compared to the European Healthcare Services industry average (2.8x)

Price to Sales Ratio vs Fair Ratio

What is 7UK0's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

7UK0 PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio	0.0004x
Fair PS Ratio	n/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate 7UK0's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Sensus Healthcare

US$143.9m

A medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide.

5TX

US$8.25

4.4%

263.8%

Shandong Weigao Group Medical Polymer

HK$20.2b

Engages in the research and development, production, wholesale, and sale of medical devices in the People’s Republic of China.

UK2

HK$0.52

-1.9%

-37.7%

LNA Santé

€240.3m

Engages in the management and operation of health establishments.

2N3

€23.00

1.5%

17.7%